Rural Health
Resources by Topic: Prescription drug misuse
Modeling the Impact of Changing Drug Markets and Structural Determinants on HCV and/or HIV Transmission Among People Who Inject Drugs in the United States: A Rural and Urban Comparison
Details a study exploring the impact of changing patterns of drug use in rural and urban areas are affecting the rates of hepatitis C virus (HCV) and HIV incidence among people who inject drugs (PWID). Compares rates of infection and drug use in San Diego, CA and rural Central and Northern, WI.
Author(s): Natasha K. Martin, Daniela Abramovitz, William H. Eger, et al.
Citation: International Journal of Drug Policy, 143, 104925
Date: 09/2025
view details
Details a study exploring the impact of changing patterns of drug use in rural and urban areas are affecting the rates of hepatitis C virus (HCV) and HIV incidence among people who inject drugs (PWID). Compares rates of infection and drug use in San Diego, CA and rural Central and Northern, WI.
Author(s): Natasha K. Martin, Daniela Abramovitz, William H. Eger, et al.
Citation: International Journal of Drug Policy, 143, 104925
Date: 09/2025
view details
Treatment Initiations and Opioid Overdoses among Recently Incarcerated People after Adoption of the Take-Home Methadone Policy
Explores the effect flexible methadone policies implemented during the COVID-19 pandemic had on opioid overdoses and treatment initiation and uptake among incarcerated people upon release. Highlights the effect this policy had on rural areas and communities that lack access to opioid treatment.
Author(s): Benjamin A. Barsky, Shapei Yan, Meredith B. Rosenthal
Citation: Drug and Alcohol Dependence, 274, 112775
Date: 09/2025
view details
Explores the effect flexible methadone policies implemented during the COVID-19 pandemic had on opioid overdoses and treatment initiation and uptake among incarcerated people upon release. Highlights the effect this policy had on rural areas and communities that lack access to opioid treatment.
Author(s): Benjamin A. Barsky, Shapei Yan, Meredith B. Rosenthal
Citation: Drug and Alcohol Dependence, 274, 112775
Date: 09/2025
view details
Pharmacy Barriers to Receiving Buprenorphine Among Patients Undergoing Telemedicine Addiction Treatment
Presents a study exploring pharmacy-level barriers experienced by patients with opioid use disorder who are receiving treatment via telemedicine. Discusses barriers that lead to missed doses or inaccessible prescriptions. Breaks down data by health and demographic characteristics, such as age, education, and insurance type, among others, and whether the patient lived in a rural or nonrural area.
Author(s): Lauren E. Hendy, Lucas G. Hill, Amanda Olguin, et al.
Citation: JAMA Network Open, 8(8), e2527418
Date: 08/2025
view details
Presents a study exploring pharmacy-level barriers experienced by patients with opioid use disorder who are receiving treatment via telemedicine. Discusses barriers that lead to missed doses or inaccessible prescriptions. Breaks down data by health and demographic characteristics, such as age, education, and insurance type, among others, and whether the patient lived in a rural or nonrural area.
Author(s): Lauren E. Hendy, Lucas G. Hill, Amanda Olguin, et al.
Citation: JAMA Network Open, 8(8), e2527418
Date: 08/2025
view details
Opportunities for Employers to Address the Opioid Epidemic: Results from a National Survey
Surveys 1,010 employees to learn their perspective on the Recovery-Ready Workplace (RRW) framework, a federally created opioid intervention for employers. Evaluates the implementation of the 4 areas addressed by RRW, noting areas for improvement related to Narcan access, stigma, and work arrangements that accommodate treatment.
Author(s): Gillian K. SteelFisher, Brian C. Castrucci, Mary G. Findling, et al.
Citation: Health Affairs Scholar, 3(8)
Date: 08/2025
view details
Surveys 1,010 employees to learn their perspective on the Recovery-Ready Workplace (RRW) framework, a federally created opioid intervention for employers. Evaluates the implementation of the 4 areas addressed by RRW, noting areas for improvement related to Narcan access, stigma, and work arrangements that accommodate treatment.
Author(s): Gillian K. SteelFisher, Brian C. Castrucci, Mary G. Findling, et al.
Citation: Health Affairs Scholar, 3(8)
Date: 08/2025
view details
Examining Geographic Disparities in Access to No-Cost Naloxone in North Carolina: A Cross-Sectional Survey of Naloxone Distribution Programs
Presents a study exploring the geographic distribution of no-cost naloxone in North Carolina. Bases findings on a survey of naloxone distributors in the state and breaks down data by user demographics and distributor type.
Author(s): Grace Marley, Caroline Shubel, Carolyn T. Thorpe, et al.
Citation: Journal of Rural Health, 41(3), e70069
Date: 08/2025
view details
Presents a study exploring the geographic distribution of no-cost naloxone in North Carolina. Bases findings on a survey of naloxone distributors in the state and breaks down data by user demographics and distributor type.
Author(s): Grace Marley, Caroline Shubel, Carolyn T. Thorpe, et al.
Citation: Journal of Rural Health, 41(3), e70069
Date: 08/2025
view details
Illegally Made Fentanyl Use in the United States: 2022 and 2023
Report highlights findings from the 2022 and 2023 National Survey on Drug Use and Health (NSDUH) on the use of illegally made fentanyl across the U.S. Explores co-usage with other drugs, emergency room visits/hospitalizations, and breaks down user characteristics by age, poverty level, and rurality, among other measures.
Citation: NSDUH Data Brief, 2(2)
Date: 07/2025
Sponsoring organizations: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration
view details
Report highlights findings from the 2022 and 2023 National Survey on Drug Use and Health (NSDUH) on the use of illegally made fentanyl across the U.S. Explores co-usage with other drugs, emergency room visits/hospitalizations, and breaks down user characteristics by age, poverty level, and rurality, among other measures.
Citation: NSDUH Data Brief, 2(2)
Date: 07/2025
Sponsoring organizations: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration
view details
Evaluation of the Maternal Opioid Misuse (MOM) Model: Fourth Annual Report (Implementation Year 3)
Provides an overview of the Maternal Opioid Misuse Model, which provides evidence-based integrated care and care coordination for pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD). Describes activities MOM Model awardees undertook during the MOM Model's second implementation year, July 1, 2023–June 30, 2024, and summarizes qualitative and beneficiary-level process data findings by state awardee. Discusses barriers pregnant and postpartum women with OUD face in accessing high-quality, continuous care, specifically in rural areas.
Additional links: Findings at a Glance
Date: 06/2025
Sponsoring organizations: Centers for Medicare and Medicaid Services, Westat
view details
Provides an overview of the Maternal Opioid Misuse Model, which provides evidence-based integrated care and care coordination for pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD). Describes activities MOM Model awardees undertook during the MOM Model's second implementation year, July 1, 2023–June 30, 2024, and summarizes qualitative and beneficiary-level process data findings by state awardee. Discusses barriers pregnant and postpartum women with OUD face in accessing high-quality, continuous care, specifically in rural areas.
Additional links: Findings at a Glance
Date: 06/2025
Sponsoring organizations: Centers for Medicare and Medicaid Services, Westat
view details
The Opioid Epidemic in Rural Communities: Can Telehealth Increase Access to Medication for Opioid Use Disorder and Offset Barriers to Care?
Examines the impact of telehealth on access to medication for opioid use disorder (MOUD) and substance and opioid use disorder (SUD/OUD) treatment. Utilizes data from the Rural Communities Opioid Response Program's (RCORP) consortia, the National Survey of Drug Use and Health (NSDUH), and the U.S. Census Bureau's American Community Survey (ACS) to analyze access to MOUD and rates of telehealth use for rural consortia. Discusses potential barriers and factors impacting telehealth implementation for SUD/OUD care.
Author(s): Kathleen Meyers, Shannon Herman, Heather Schuler, et al.
Citation: Drug and Alcohol Dependence, 271, 112628
Date: 06/2025
view details
Examines the impact of telehealth on access to medication for opioid use disorder (MOUD) and substance and opioid use disorder (SUD/OUD) treatment. Utilizes data from the Rural Communities Opioid Response Program's (RCORP) consortia, the National Survey of Drug Use and Health (NSDUH), and the U.S. Census Bureau's American Community Survey (ACS) to analyze access to MOUD and rates of telehealth use for rural consortia. Discusses potential barriers and factors impacting telehealth implementation for SUD/OUD care.
Author(s): Kathleen Meyers, Shannon Herman, Heather Schuler, et al.
Citation: Drug and Alcohol Dependence, 271, 112628
Date: 06/2025
view details
Discreet but Accessible: A Qualitative Study with People Who Use Drugs and Service Staff about the Optimal Design of a Harm Reduction Vending Machine in Rural Kentucky
Analyzes perspectives on harm reduction vending machine (HRVM) access and suitability via interviews with people who use drugs as well as health department and syringe service program (SSP) staff in rural Appalachian Kentucky. Discusses factors influencing the usefulness of HRVMs and their ability to address public health needs such as infectious disease prevention, overdose reduction, and other community benefits.
Author(s): Rachel M. Marschke, April M. Young, Hannah K. Knudsen, Chelsi N. Cheatom, Hannah L. F. Cooper
Citation: Harm Reduction Journal, 22, 88
Date: 05/2025
view details
Analyzes perspectives on harm reduction vending machine (HRVM) access and suitability via interviews with people who use drugs as well as health department and syringe service program (SSP) staff in rural Appalachian Kentucky. Discusses factors influencing the usefulness of HRVMs and their ability to address public health needs such as infectious disease prevention, overdose reduction, and other community benefits.
Author(s): Rachel M. Marschke, April M. Young, Hannah K. Knudsen, Chelsi N. Cheatom, Hannah L. F. Cooper
Citation: Harm Reduction Journal, 22, 88
Date: 05/2025
view details
Rural Access to Certified Community Behavioral Health Clinics (CCBHCs)
Examines access to, and services offered by, Certified Community Behavioral Health Clinics (CCBHCs) in rural and urban communities. Also compares services at CCBHCs with those offered at other mental health clinics. Features state-level maps showing CCBHC counts by state, and statistics on services counts in CCBHCs and other mental health facilities, with breakdowns by urban and rural areas.
Author(s): Aaron P. Smith, Jeffrey Talbert
Date: 05/2025
Sponsoring organization: Rural and Underserved Health Research Center
view details
Examines access to, and services offered by, Certified Community Behavioral Health Clinics (CCBHCs) in rural and urban communities. Also compares services at CCBHCs with those offered at other mental health clinics. Features state-level maps showing CCBHC counts by state, and statistics on services counts in CCBHCs and other mental health facilities, with breakdowns by urban and rural areas.
Author(s): Aaron P. Smith, Jeffrey Talbert
Date: 05/2025
Sponsoring organization: Rural and Underserved Health Research Center
view details